Skip to main content
FinSpry Logo
FinSpry
LXRX logo
LXRX
(NASDAQ)
Lexicon Pharmaceuticals, Inc.
$2.29-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lexicon Pharmaceuticals (LXRX) Stock Price & Financial Analysis

Lexicon Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.98 - $2.10
52-Week High$2.53
52-Week Low$0.71
Open$2.04
Volume3.92M
Average Volume (3M)2.94M
Market Cap804.48M
Shares Outstanding400.24M
Price to Sales (P/S)11.55
Price to Book (P/B)3.97
EV/EBITDA-47.25
Revenue (TTM)69.64M
Net Income (TTM)-26.09M
Free Cash Flow (TTM)-38.80M
EPS (TTM)$-0.07
Profit Margin-37.46%
Operating Margin-34.79%
Return on Equity (ROE)-12.86%
Debt to Equity0.28
50-Day MA$1.93
200-Day MA$1.52
52-Week Change169.62%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lexicon Pharmaceuticals

What is the current stock price for LXRX?

As of the latest trading session, LXRX stock trades at $2.01. The 52-week range is $0.71–$2.53, with a day range of $1.98–$2.10.

What is the P/E ratio for LXRX?

The P/E ratio (Price-to-Earnings) for LXRX is shown in the Key Statistics section. This valuation metric helps compare Lexicon Pharmaceuticals, Inc. to industry peers.

Does LXRX pay dividends?

Lexicon Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LXRX?

Based on 1 analyst, the consensus for LXRX is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LXRX?

Lexicon Pharmaceuticals's market capitalization is $804.5M, classifying it as a small-cap company. Lexicon Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.